siRNA Functionalized Lipid Nanoparticles (LNPs) in Management of Diseases.

Kalita, Tutu; Dezfouli, Saba Abbasi; Pandey, Lalit M; Uludag, Hasan

Kalita, Tutu; Dezfouli, Saba Abbasi; Pandey, Lalit M; Uludag, Hasan.

Afiliação

Kalita T; Bio-Interface & Environmental Engineering Lab, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India.
Dezfouli SA; Department of Chemical & Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, AB T6G 2V2, Canada.
Pandey LM; Bio-Interface & Environmental Engineering Lab, Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati 781039, India.
Uludag H; Department of Chemical & Materials Engineering, Faculty of Engineering, University of Alberta, Edmonton, AB T6G 2V2, Canada.

Pharmaceutics ; 14(11)2022 Nov 19.

Article em En | MEDLINE | ID: mdl-36432711

Palavras-chave

COVID-19; cancer; hepatitis B; lipid nanoparticles; nanotechnology; siRNA; surface modification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google